Role of oral rehydration in the treatment of children with rotavirus infection

Q3 Medicine
K. Ermolenko
{"title":"Role of oral rehydration in the treatment of children with rotavirus infection","authors":"K. Ermolenko","doi":"10.20953/1817-7646-2022-6-55-60","DOIUrl":null,"url":null,"abstract":"Rotavirus infection (RVI) has always been one of the urgent problems in healthcare causing significant economic and social damage. Correction of water-electrolyte disorders is pivotal for RVI therapy. The severity of the dehydration largely determines the overall severity of the disease. It is often challenging to choose the most effective rehydration solution; therefore, inadequate choice is the most common treatment error in patients with acute intestinal infections. Objective. To assess the efficacy of oral rehydration in children with acute gastroenteritis caused by rotavirus treated in an outpatient department. Patients and methods. This retrospective, open-label, case-control study included 100 children with RVI treated in 2021–2022. They were divided into three groups. In group I, patients received water or self-made solutions for rehydration; in group II, patients received oral rehydration therapy (ORT) with different commercial solutions; in group III, patients received Nestle ReHydra. We evaluated the severity and duration of RVI symptoms, including diarrhea, vomiting, abdominal pain, flatulence, general symptoms of intoxication, and signs of exicosis. Results. The lowest duration of diarrhea, vomiting, flatulence, and bloating was observed in group III. The duration of RVI symptoms in children receiving low osmolar ORT was 1.2-1.4 times lower than in those who did not receive this therapy. We found that low osmolar ORTs are the most effective agents to treat dehydration in children. Oral rehydration with ready-touse ORTs is preferable, because they can be rapidly prepared and administered and prevent mistakes associated with drug preparation. Conclusion. Oral rehydration with low osmolar ORT in children with RVI increases the efficacy of outpatient treatment, reduce the duration of clinical symptoms, and decrease the risks of severe dehydration that requires inpatient treatment. Key words: acute intestinal infections, dehydration, low osmolar solutions, diarrhea, oral rehydration","PeriodicalId":38157,"journal":{"name":"Voprosy Prakticheskoi Pediatrii","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Voprosy Prakticheskoi Pediatrii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20953/1817-7646-2022-6-55-60","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Rotavirus infection (RVI) has always been one of the urgent problems in healthcare causing significant economic and social damage. Correction of water-electrolyte disorders is pivotal for RVI therapy. The severity of the dehydration largely determines the overall severity of the disease. It is often challenging to choose the most effective rehydration solution; therefore, inadequate choice is the most common treatment error in patients with acute intestinal infections. Objective. To assess the efficacy of oral rehydration in children with acute gastroenteritis caused by rotavirus treated in an outpatient department. Patients and methods. This retrospective, open-label, case-control study included 100 children with RVI treated in 2021–2022. They were divided into three groups. In group I, patients received water or self-made solutions for rehydration; in group II, patients received oral rehydration therapy (ORT) with different commercial solutions; in group III, patients received Nestle ReHydra. We evaluated the severity and duration of RVI symptoms, including diarrhea, vomiting, abdominal pain, flatulence, general symptoms of intoxication, and signs of exicosis. Results. The lowest duration of diarrhea, vomiting, flatulence, and bloating was observed in group III. The duration of RVI symptoms in children receiving low osmolar ORT was 1.2-1.4 times lower than in those who did not receive this therapy. We found that low osmolar ORTs are the most effective agents to treat dehydration in children. Oral rehydration with ready-touse ORTs is preferable, because they can be rapidly prepared and administered and prevent mistakes associated with drug preparation. Conclusion. Oral rehydration with low osmolar ORT in children with RVI increases the efficacy of outpatient treatment, reduce the duration of clinical symptoms, and decrease the risks of severe dehydration that requires inpatient treatment. Key words: acute intestinal infections, dehydration, low osmolar solutions, diarrhea, oral rehydration
口服补液在儿童轮状病毒感染治疗中的作用
轮状病毒感染(RVI)一直是医疗卫生领域亟待解决的问题之一,造成了巨大的经济和社会损失。纠正水电解质紊乱是RVI治疗的关键。脱水的严重程度在很大程度上决定了疾病的整体严重程度。选择最有效的补水溶液往往是一项挑战;因此,选择不当是急性肠道感染患者最常见的治疗错误。目标。评价门诊治疗的轮状病毒急性胃肠炎患儿口服补液的疗效。患者和方法。这项回顾性、开放标签、病例对照研究包括100名在2021-2022年接受RVI治疗的儿童。他们被分成三组。第一组患者接受水或自制溶液补液;II组患者接受不同商业溶液的口服补液治疗(ORT);第三组患者接受雀巢ReHydra治疗。我们评估了RVI症状的严重程度和持续时间,包括腹泻、呕吐、腹痛、肠胃胀气、中毒的一般症状和中毒的迹象。结果。第三组腹泻、呕吐、胀气和腹胀持续时间最短。接受低渗透压ORT治疗的儿童RVI症状持续时间比未接受该治疗的儿童短1.2-1.4倍。我们发现低渗透压ort是治疗儿童脱水最有效的药物。口服补液与即用型口服口服补液是可取的,因为它们可以快速制备和给药,并防止与药物制备相关的错误。结论。低渗透压ORT的RVI患儿口服补液可提高门诊治疗的疗效,缩短临床症状持续时间,降低需要住院治疗的严重脱水风险。关键词:急性肠道感染,脱水,低渗透压溶液,腹泻,口服补液
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Voprosy Prakticheskoi Pediatrii
Voprosy Prakticheskoi Pediatrii Medicine-Pediatrics, Perinatology and Child Health
CiteScore
1.20
自引率
0.00%
发文量
50
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信